Literature DB >> 15021237

Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair.

Ephron S Rosenzweig1, John W McDonald.   

Abstract

PURPOSE OF REVIEW: In this review, we have documented some current research trends in rodent models of spinal cord injury. We have also catalogued the treatments used in studies published between October 2002 and November 2003, with special attention given to studies in which treatments were delayed for at least 4 days after injury. RECENT
FINDINGS: Most spinal cord injury studies are performed with one of three general injury models: transection, compression, or contusion. Although most treatments are begun immediately after injury, a growing number of studies have used delayed interventions. Mice and the genetic tools they offer are gaining in popularity. Some researchers are setting their sights beyond locomotion, to issues more pressing for people with spinal cord injury (especially bladder function and pain).
SUMMARY: Delayed treatment protocols may extend the window of opportunity for treatment of spinal cord injury, whereas continued progress in the prevention of secondary cell death will reduce the severity of new cases. The use of mice will hopefully accelerate progress towards useful regeneration in humans. Researchers must improve cross-study comparability to allow balanced decisions about potentially useful treatments.

Entities:  

Mesh:

Year:  2004        PMID: 15021237     DOI: 10.1097/00019052-200404000-00007

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  31 in total

Review 1.  A systematic review of exercise training to promote locomotor recovery in animal models of spinal cord injury.

Authors:  Camila R Battistuzzo; Robert J Callister; Robin Callister; Mary P Galea
Journal:  J Neurotrauma       Date:  2012-04-18       Impact factor: 5.269

2.  Design and assessment of a potent sodium channel blocking derivative of mexiletine for minimizing experimental neuropathic pain in several rat models.

Authors:  Robert M Weston; Kamani R Subasinghe; Vasiliki Staikopoulos; Bevyn Jarrott
Journal:  Neurochem Res       Date:  2009-06-06       Impact factor: 3.996

3.  Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS.

Authors:  John Dill; Hongyu Wang; Fengquan Zhou; Shuxin Li
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

Review 4.  MRI in rodent models of brain disorders.

Authors:  Aleksandar Denic; Slobodan I Macura; Prasanna Mishra; Jeffrey D Gamez; Moses Rodriguez; Istvan Pirko
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

5.  Modulating Sema3A signal with a L1 mimetic peptide is not sufficient to promote motor recovery and axon regeneration after spinal cord injury.

Authors:  Erik Mire; Nicole Thomasset; Lyn B Jakeman; Geneviève Rougon
Journal:  Mol Cell Neurosci       Date:  2007-10-03       Impact factor: 4.314

Review 6.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

7.  Long-term Follow-up of Cutaneous Hypersensitivity in Rats with a Spinal Cord Contusion.

Authors:  Ji-In Jung; Junesun Kim; Seung Kil Hong; Young Wook Yoon
Journal:  Korean J Physiol Pharmacol       Date:  2008-12-31       Impact factor: 2.016

8.  L1 cell adhesion molecule is essential for the maintenance of hyperalgesia after spinal cord injury.

Authors:  Emily L Hoschouer; Feng Qin Yin; Lyn B Jakeman
Journal:  Exp Neurol       Date:  2008-11-13       Impact factor: 5.330

9.  Evaluating regional blood spinal cord barrier dysfunction following spinal cord injury using longitudinal dynamic contrast-enhanced MRI.

Authors:  Ilkan Tatar; Peter Cheng-te Chou; Mohamed Mokhtar Desouki; Hanaa El Sayed; Mehmet Bilgen
Journal:  BMC Med Imaging       Date:  2009-06-11       Impact factor: 1.930

10.  Critical involvement of Rho GTPase activity in the efficient transplantation of neural stem cells into the injured spinal cord.

Authors:  Fujiki Numano; Akihiro Inoue; Mitsuhiro Enomoto; Kenichi Shinomiya; Atsushi Okawa; Shigeo Okabe
Journal:  Mol Brain       Date:  2009-11-28       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.